Publication | Open Access
The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study
57
Citations
18
References
2019
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1